Milestone Pharmaceuticals Inc. - Common Shares — movimiento de fondos (NASDAQ:MIST) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas -50.73 M-33.22 M-52.47 M-46.42 M-28.85 M-49.04 M -51.14 M Flujo de caja de las actividades de inversión -70 M70 M-57.12 M4.76 M8.28 M11.25 M -102.37 M Flujo de caja de las actividades financieras 73.22 M5.05 M3.09 M47.79 M32.12 M85.53 M 179.74 M Flujo de caja libre -50.73 M-33.22 M-52.47 M-46.42 M-28.85 M-49.34 M -51.48 M

Noticias

Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript

Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales - Milestone Pharmaceuticals (NASDAQ:MIST

Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates

Milestone Pharmaceuticals no alcanza por 0,43$ las previsiones de BPA en el primer trimestre del año

Las acciones de Milestone Pharmaceuticals caen un 16% por decepción en ingresos

Milestone Pharmaceuticals planea estudio de registro PSVT del mundo real

Raymond James inicia cobertura de Milestone Pharmaceuticals con recomendación de Compra Fuerte

Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript

Milestone Pharmaceuticals cumple previsión de BPA, acción cae

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Milestone Pharmaceuticals (NASDAQ:MIST)

Milestone Stock: Downgrading To Sell As CARDAMYST Faces A Tough Reality (NASDAQ:MIST)

Milestone Pharmaceuticals appoints David Sandoval as general counsel